This Day On The Street
Continue to site right-arrow
ADVERTISEMENT
This account is pending registration confirmation. Please click on the link within the confirmation email previously sent you to complete registration.
Need a new registration confirmation email? Click here
Stocks Under $10 with 50-100% upside potential - 14 days FREE!

BonAlive Biomaterials Ltd Receives CE-mark For Osteostimulative BonAliveA® Putty

TURKU, Finland, November 22, 2013 /PRNewswire/ --

BonAlive Biomaterials Ltd ,  a manufacturer of implantable medical devices ,  today announced the launch of a patented ,  ready-to-use and mouldable version of their osteostimulative BonAlive ®   bioactive glass bone regeneration technology.

The launch of the osteostimulative BonAlive ® putty is an important milestone in the commercialization strategy of the BonAlive ® product family. The current BonAlive ® granules products have been approved for orthopaedic use since 2006 and for bone cavity filling in the treatment of chronic osteomyelitis since March 2011. "As an extension to the BonAlive ® granules product line, the BonAlive ® putty will significantly strengthen our position in the trauma and spine market as surgeons are increasingly demanding products that are both easy and ready-to-use while delivering a solid clinical outcome" said Dr. Fredrik Ollila, CEO of BonAlive Biomaterials Ltd.

For more information about BonAlive Biomaterials Ltd, please visit http://www.bonalive.com.

About BonAlive Biomaterials Ltd

BonAlive Biomaterials Ltd is an emerging leader in the field of implantable medical devices for bone regeneration. The company provides world-leading biomaterial solutions for the treatment of chronically infected bone. BonAlive ® products are available in Europe, Middle East, Asia-Pacific, Africa, Brazil and the USA through a professional distributor network. The clinical use of BonAlive ® bioactive glass is supported by a twenty year research history including several randomized prospective trials in the field of spine, benign bone tumour and trauma surgery. More than fifty peer reviewed articles have been published relating to BonAlive ® products.

For questions or additional information ,  please contact: BonAlive Biomaterials Ltd Dr. Fredrik Ollila ,  Chief executive officer Phone:   +358400931209 Email:    fredrik.ollila@bonalive.com

SOURCE BonAlive Biomaterials Ltd

Copyright 2011 PR Newswire. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.

Select the service that is right for you!

COMPARE ALL SERVICES
Action Alerts PLUS
Try it NOW

Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.

Product Features:
  • $2.5+ million portfolio
  • Large-cap and dividend focus
  • Intraday trade alerts from Cramer
  • Weekly roundups
TheStreet Quant Ratings
Try it NOW
Only $49.95/yr

Access the tool that DOMINATES the Russell 2000 and the S&P 500.

Product Features:
  • Buy, hold, or sell recommendations for over 4,300 stocks
  • Unlimited research reports on your favorite stocks
  • A custom stock screener
  • Upgrade/downgrade alerts
Stocks Under $10
Try it NOW

David Peltier, uncovers low dollar stocks with extraordinary upside potential that are flying under Wall Street's radar.

Product Features:
  • Model portfolio
  • Stocks trading below $10
  • Intraday trade alerts
  • Weekly roundups
Dividend Stock Advisor
Try it NOW

Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.

Product Features:
  • Diversified model portfolio of dividend stocks
  • Alerts when market news affect the portfolio
  • Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
Real Money Pro
Try it NOW

All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.

Product Features:
  • Real Money + Doug Kass Plus 15 more Wall Street Pros
  • Intraday commentary & news
  • Ultra-actionable trading ideas
Options Profits
Try it NOW

Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.

Product Features:
  • 100+ monthly options trading ideas
  • Actionable options commentary & news
  • Real-time trading community
  • Options TV
To begin commenting right away, you can log in below using your Disqus, Facebook, Twitter, OpenID or Yahoo login credentials. Alternatively, you can post a comment as a "guest" just by entering an email address. Your use of the commenting tool is subject to multiple terms of service/use and privacy policies - see here for more details.
Submit an article to us!

Markets

DOW 17,804.80 +26.65 0.15%
S&P 500 2,070.65 +9.42 0.46%
NASDAQ 4,765.38 +16.9840 0.36%

Brokerage Partners

Rates from Bankrate.com

  • Mortgage
  • Credit Cards
  • Auto

Free Newsletters from TheStreet

My Subscriptions:

After the Bell

Before the Bell

Booyah! Newsletter

Midday Bell

TheStreet Top 10 Stories

Winners & Losers

Register for Newsletters
Top Rated Stocks Top Rated Funds Top Rated ETFs